• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧氟沙星治疗中耳炎

Chemotherapy of otitis media with ofloxacin.

作者信息

Lenarz T

机构信息

ENT Department, University of Heidelberg.

出版信息

Drugs. 1987;34 Suppl 1:139-43. doi: 10.2165/00003495-198700341-00030.

DOI:10.2165/00003495-198700341-00030
PMID:3481314
Abstract

This study evaluated the therapeutic role of ofloxacin in different forms of otitis media. After identifying the infecting bacteria in 250 patients with acute otitis media, or chronic otitis media, the clinical efficacy of orally administered ofloxacin 200mg twice daily was assessed in 45 patients from each of these groups. The clinical results were comparable with those obtained after conventional local and oral antibiotic therapy. Microbiological examination of the ear secretions revealed Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae and Haemophilus influenzae to be the main pathogens in acute otitis media, whereas in chronic otitis media P. aeruginosa and Proteus sp. were detected in most of the cases. Ofloxacin concentrations in secretions and mucosa specimens of the middle ear exceeded serum concentrations by more than 2-fold. On the basis of these preliminary results, ofloxacin appears to be an effective orally administered agent, without ototoxicity, which is effective against S. aureus and P. aeruginosa, 2 important pathogens in middle ear infections. Ofloxacin should be considered as an alternative for the therapy of otitis media, especially the chronic forms.

摘要

本研究评估了氧氟沙星在不同类型中耳炎中的治疗作用。在确定250例急性中耳炎或慢性中耳炎患者的感染细菌后,对每组45例患者评估了每日口服200mg氧氟沙星两次的临床疗效。临床结果与传统局部及口服抗生素治疗后的结果相当。耳部分泌物的微生物学检查显示,金黄色葡萄球菌、化脓性链球菌、肺炎链球菌和流感嗜血杆菌是急性中耳炎的主要病原体,而在慢性中耳炎中,大多数病例检测到铜绿假单胞菌和变形杆菌属。中耳分泌物和黏膜标本中的氧氟沙星浓度超过血清浓度两倍以上。基于这些初步结果,氧氟沙星似乎是一种有效的口服药物,无耳毒性,对金黄色葡萄球菌和铜绿假单胞菌有效,这两种是中耳感染中的重要病原体。氧氟沙星应被视为中耳炎治疗的替代药物,尤其是慢性中耳炎。

相似文献

1
Chemotherapy of otitis media with ofloxacin.氧氟沙星治疗中耳炎
Drugs. 1987;34 Suppl 1:139-43. doi: 10.2165/00003495-198700341-00030.
2
Ofloxacin in oral chemotherapy of acute and chronic otitis media.氧氟沙星在急慢性中耳炎口服化疗中的应用。
Infection. 1986;14 Suppl 4:S324-6. doi: 10.1007/BF01661309.
3
[Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences].氧氟沙星在急慢性中耳炎保守治疗中的应用——初步临床经验报告
Infection. 1986;14 Suppl 1:S87-8. doi: 10.1007/BF01645208.
4
In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
Pediatr Infect Dis J. 2001 Jan;20(1):102-3; discussion 120-2. doi: 10.1097/00006454-200101000-00037.
5
Effectiveness and safety of ofloxacin in chronic otitis media and chronic sinusitis in adult outpatients.氧氟沙星对成年门诊患者慢性中耳炎和慢性鼻窦炎的有效性与安全性。 需注意,原英文文本中“of ofloxacin”表述有误,多了一个“of” 。
Eur Arch Otorhinolaryngol. 1993;250 Suppl 1:S13-4. doi: 10.1007/BF02540110.
6
Antimicrobial treatment of otitis media.中耳炎的抗菌治疗。
Semin Respir Infect. 1991 Jun;6(2):85-93.
7
An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.一项关于左氧氟沙星治疗复发性或持续性急性中耳炎患儿或高危患儿的开放标签、双次鼓膜穿刺研究。
Pediatr Infect Dis J. 2006 Dec;25(12):1102-9. doi: 10.1097/01.inf.0000246828.13834.f9.
8
[Ofloxacin in the treatment of Pseudomonas aeruginosa infections of the ear].
HNO. 1988 Jun;36(6):230-3.
9
Tissue concentrations of ofloxacin in the middle ear.中耳中氧氟沙星的组织浓度。 (注:原文中多了一个of,正确表述应该是Tissue concentrations of ofloxacin in the middle ear.)
Clin Ther. 1987;9(5):523-7.
10
[Evaluation of antibiotic resistance in material isolated from the middle ear in children with acute otitis media not responding to standard antibiotic treatment].[对标准抗生素治疗无反应的急性中耳炎患儿中耳分离材料中抗生素耐药性的评估]
Otolaryngol Pol. 2007;61(5):892-7. doi: 10.1016/S0030-6657(07)70550-4.

引用本文的文献

1
Protective effects of local administration of ciprofloxacin on the risk of pneumococcal meningitis after cochlear implantation.局部应用环丙沙星对人工耳蜗植入术后肺炎球菌性脑膜炎风险的保护作用。
Laryngoscope. 2006 Dec;116(12):2138-44. doi: 10.1097/01.mlg.0000243192.43574.81.
2
Concentrations of ofloxacin in ear and nasal tissues.耳部和鼻部组织中氧氟沙星的浓度。
Eur Arch Otorhinolaryngol. 1993;250 Suppl 1:S7-11. doi: 10.1007/BF02540109.
3
Clinical experiences with ofloxacin sequential therapy in chronic ear infections.

本文引用的文献

1
Mutational resistance to 4-quinolone antibacterial agents.对4-喹诺酮类抗菌药物的突变耐药性。
Eur J Clin Microbiol. 1984 Aug;3(4):347-50. doi: 10.1007/BF01977492.
2
Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.氧氟沙星的剂量线性及其他药代动力学:一种新型广谱抗菌剂。
Pharmatherapeutica. 1985;4(6):376-82.
3
Ofloxacin in oral chemotherapy of acute and chronic otitis media.氧氟沙星在急慢性中耳炎口服化疗中的应用。
Eur Arch Otorhinolaryngol. 1993;250 Suppl 1:S19-21. doi: 10.1007/BF02540112.
4
Granulation tissue concentrations of ofloxacin after oral administration in invasive external otitis.
Eur Arch Otorhinolaryngol. 1993;250 Suppl 1:S15-7. doi: 10.1007/BF02540111.
5
Tissue and serum concentrations of ofloxacin in the ear region following a single daily oral dose of 400 mg.每日单次口服400毫克氧氟沙星后耳部组织和血清中的浓度
Infection. 1993 Jan-Feb;21(1):63-5. doi: 10.1007/BF01739319.
Infection. 1986;14 Suppl 4:S324-6. doi: 10.1007/BF01661309.
4
[Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences].氧氟沙星在急慢性中耳炎保守治疗中的应用——初步临床经验报告
Infection. 1986;14 Suppl 1:S87-8. doi: 10.1007/BF01645208.
5
[Tissue concentration and effectiveness of ofloxacin in surgical patients].
Infection. 1986;14 Suppl 1:S70-2. doi: 10.1007/BF01645204.
6
[New oral quinolone compounds in chronic bronchitis].[慢性支气管炎中的新型口服喹诺酮类化合物]
Infection. 1986;14 Suppl 1:S73-8. doi: 10.1007/BF01645205.